Pectin-based double network hydrogels as local depots of celastrol for enhanced antitumor therapy

In this study, A double-network (DN) hydrogel composed of a physical glycyrrhizic acid (GA) network and a chemically crosslinked pectin-based network was fabricated as a local depot of celastrol (CEL) for cancer treatment. The obtained DN hydrogel possessed excellent mechanical performance, flexibility, biocompatibility, biodegradability and self-healing property. Furthermore, the release profile of CEL loaded DN hydrogel maintained a controlled and sustained release of CEL for a prolonged period. Finally, in vivo animal experiments demonstrated that the DN hydrogel could significantly enhance the therapeutic efficiency of CEL in CT-26 tumorbearing mice upon intratumoral injection while effectively alleviate the toxicity of the CEL. In summary, this injectable pectin-based double network hydrogels are ideal delivery vehicle for tumor therapy.

Automated summary

A double-network hydrogel composed of a physical glycyrrhizic acid network and a chemically crosslinked pectin-based network was fabricated as a local drug depot. It exhibited excellent mechanical performance, biocompatibility, biodegradability, and sustained drug release.